Richard Reinking
Family Medicine · Tulsa, OKNPI 1639178403
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,200 and has fallen 97.4% since, to $32 in 2024.
Across 86 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$263
- Pfizer$89
- Boehringer Ingelheim$75
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$73
- Sanofi-aventis U.S. LLC$73
- Johnson & Johnson$73
- plus $626 from 20 others
What the payments were for
- Food & beverage$1,273100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $263 |
| Pfizer | 6 | $89 |
| Boehringer Ingelheim | 6 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $73 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Johnson & Johnson | 5 | $73 |
| E.r. Squibb & Sons, L.L.C. | 5 | $70 |
| Aytu Biopharma, Inc. | 5 | $66 |
| AbbVie(2 entities) | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Novo Nordisk | 2 | $44 |
| Abbott | 3 | $37 |
| Astellas Pharma US Inc | 2 | $33 |
| Amgen | 2 | $32 |
| AstraZeneca | 2 | $32 |
| Abiomed | 1 | $32 |
| Boston Scientific | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Merck | 2 | $23 |
| Phadia US Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| GSK | 1 | $12 |
How this compares
$1,273 in reported general payments places this provider in the 65th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Tulsa
- Geoffrey PlumleeTulsa$297K
- Kimberly HuttonTulsa$76K
- Sarah HallTulsa$52K
- Candy TingTulsa$28K
- Scott GhereTulsa$27K
- Michael MaddoxTulsa$24K
- Randall HerbelTulsa$23K
- Chandan LadTulsa$22K
- Scott SexterTulsa$21K
- Scott KochTulsa$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.